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Aims: To assess the relationship between depression and
the vision-related quality of life in patients with retinitis
pigmentosa (RP).
Methods: The study included 144 patients diagnosed as
having RP. The mean age of the patients was 38.5 (SD
13.3) years, and 42% of the subjects were women. They
answered the National Eye Institute Visual Function
Questionnaire (NEI-VFQ) to assess the vision-related
quality of life and the Beck Depression Inventory (BDI) to
assess depressive symptoms. Patients were classified
into groups with and without depression according to the
BDI score. The NEI-VFQ composite and subscale scores
were compared between groups. The correlations
between the BDI and the NEI-VFQ, weighted visual acuity
(WVA) and functional vision score (FVS) were investi-
gated.
Results: The depressed group had significantly less
subjective visual function compared with the non-
depressed group. A negative correlation was observed
between the BDI and the NEI-VFQ scores, while no
correlation was found between the BDI score and WVA or
FVS.
Conclusion: The RP patients with depression had poorer
vision-related functions compared with those patients
without depression, which cannot be explained by the
visual acuity. Interventions to diagnose and treat
depression are necessary to enhance the overall quality of
life in RP patients.
Of all types of sensory loss, loss of vision is the
most severe social and psychological disability,1
and retinitis pigmentosa (RP) is a leading cause of
inherited blindness among individuals younger
than 60 years.2 3 Although the clinical symptoms
of RP are highly variable, most patients lose their
vision by age 40, with severely constricted visual
fields due to the loss of rod and cone photoreceptor
cells.4
Visual impairment substantially impairs daily
functioning and well-being.5–7 Studies report that
old people with visual impairment have a higher
prevalence of depression compared with people
with good vision.6–8 A 4-year follow-up study of the
newly blind reported that the blind patients
showed only a minor improvement in the acquisi-
tion of compensatory skills, and a significant
portion of the patients suffered from depression
and overall poor health, with consequent func-
tional impairment.9
RP is emotionally devastating to the patients due
to their anticipated vision loss, and the subsequent
experience of gradual vision loss causes severe
distress. These factors could make RP patients
more vulnerable to depression, but few studies
have addressed the issues of depression and the
vision-related quality of life in this population.
Therefore, we assessed the depression status of RP
patients in Korea and examined how depressive
symptoms affect their subjective visual function
and vision-related quality of life.
METHODS
Subjects
The patients were recruited through advertise-
ments from the outpatient clinic at Seoul National
University Hospital (SNUH) and the Korean
Retinitis Pigmentosa Society, a non-profit support
network for Korean RP patients. All patients
volunteered to participate in a study associated
with the Korean Genome Project after being
diagnosed by ophthalmological specialists in retinal
disease at SNUH. The patients underwent a careful
fundus examination and standard electroretinogra-
phy (ERG) to confirm the diagnosis. Patients with
other ocular diseases that could affect visual
function were excluded. Initially, 152 patients
volunteered for the study, but eight patients were
excluded after the ophthalmological examination.
Five of them were diagnosed as Stargardt disease,
and three patients as choroideraemia.
Consequently, 144 patients with RP participated
in the study.
Test of visual function
Best-corrected visual acuity (VA) was measured
with Snellen’s acuity charts and transformed to
the logarithm of the minimum angle of resolution
(logMAR). The visual acuity was measured in a
standard manner. All the patients were evaluated
in the same room in which the degree of
illumination was sufficiently bright for measuring
visual acuity and not changed. For VA less than
counting fingers (CF) at 0.5 m, the following
arbitrary logMAR values were used: CF in front
of the eye, logMAR 2.2; hand movements (HM),
logMAR 2.3; light perception (LP), logMAR 2.5;
and no LP, logMAR 3. The weighted logMAR
visual acuity (WVA) was calculated and used in
the analysis.10 The monocular and binocular
kinetic visual fields were measured with
Goldmann perimetry using III/4/e isopter at
standard background luminance, and the
Binocular Visual Field Score (BVFS) was mea-
sured. Since the Functional Vision Score (FVS),
which combines the visual acuities and visual
fields into one measure, is a better measure of
functional vision in daily activity than either VA
or VF alone, FVS was also calculated and used in
the analysis.11
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Self-reported visual functioning questionnaire
The National Eye Institute Visual Functioning Questionnaire
(NEI-VFQ) was used to evaluate the patients’ subjective visual
function.12 The NEI-VFQ-25 gives an overall score, as well as 12
subscale scores: general health, general vision, near vision,
distance vision, driving, peripheral vision, colour vision, ocular
pain, vision-associated role limitations, dependency, social
functioning and mental health. The questionnaire focuses on
vision difficulties in everyday life, as well as vision-relevant
psychosocial domains, such as mental health, social function
and role difficulty. The original questionnaire was translated
into Korean separately by two independent clinical experts, a
psychiatrist and a psychologist, each with a good command of
English. The two versions of the initial translation were checked
and combined, and then back translated by a bilingual clinical
expert. A four-member translation committee comprising
healthcare professionals reviewed and agreed on a version of
the final Korean NEI-VFQ that best reflected the original,
conceptually and linguistically. The patients filled up the
package including the questionnaire for demographical informa-
tion, Beck Depression Inventory (BDI), and NEI-VFQ and their
responses were checked at the scheduled visit by a clinician
(JMS) and if there was any missing, the patients were asked to
fill up the missing. When completion was impossible due to low
vision, an interviewer administered it. The questionnaire
comprises 5-point scale ratings that were transformed to a 0–
100 scale. The overall composite NEI-VFQ scores of 11 of the 12
subscales were calculated, excluding the general health sub-
scale.13
Beck Depression Inventory
Depression in the patients with RP was assessed using the BDI,
a well standardised 21-item measure of the cognitive, affective
and somatic symptoms of depression. The BDI was developed
to assess the type and severity of depression based on clinical
symptoms,14 and is one of the most widely used self-report
instruments for measuring the severity of depressive symp-
toms. The Korean version of the BDI has been standardised
formally and a score of 16 was suggested as the optimal cut-off
score for the diagnosis of major depression in Korea.15
Therefore, in this study, a BDI score >16 was considered
indicative of depression.
Statistical analysis
The study participants were classified into two groups, a
depressed group and a non-depressed group, according to the
BDI total score (cut-off point: BDI 16). The demographic profile
for age, sex, living arrangements, education level, marital status,
socio-economic status16 and visual function as measured by the
WVA, BVFS, FVS and NEI-VFQ composite scores were
compared between the patients with and without depression,
using the t test and chi-square test for continuous and
categorical variables, respectively.
The average NEI-VFQ subscale scores between depressed and
non-depressed groups were analysed using the t test, and the
Bonferroni correction was adopted for multiple comparisons.
Since the number of current drivers was small (four depressed
vs. 17 non-depressed), the driving subscale was excluded from
the analysis. Since the violation of the homogeneity of variance
between the depressed and non-depressed group can lead to
biased results in the analysis with unequal sample size, the
Levene’s test was performed for equality of variances.
Correlations between the BDI score and NEI-VFQ average
score, as well as between the BDI score and the WVA and FVS
scores, were examined using Pearson’s correlation coefficient.
Finally, multiple linear regression analyses were performed to
determine predictive factors and their contribution to the NEI-
VFQ composite score. Covariates included factors that are
known to be associated with self-reported visual function: age,
sex, socio-economic status, marital status and education level. A
p value ,0.05 was considered significant in all analyses. Data
were analysed with SPSS 12.0 software (SPSS, Chicago).
RESULTS
The participants were generally young to middle-aged (mean
age 38.5 (SD 13.3) years) with an average duration of illness of
18.7 (12.9) years (table 1). Thirty-seven patients (25.7%) had a
BDI score >16, indicative of clinical depression in the Korean
population.
No significant differences were observed between the high
and low BDI groups with respect to socio-demographic and
clinical variables, including age, sex, education level, living
arrangement, socio-economic status, onset age and duration of
illness. Although not significant, a trend toward a higher
unmarried status was observed in the high BDI group compared
with the low BDI group (x2 = 3.26, p = 0.071).
The objective visual function as measured using the WVA,
BVFS and FVS showed no significant differences between the
high- and low-BDI groups. By contrast, the subjective vision
function and related quality of life as measured by the NEI-VFQ
composite scores differed significantly between the groups. The
high-BDI group scored over 15 points lower than the low-BDI
group (41.2 (22.6) vs. 56.7 (19.5), p,0.001). The differences
remained significant, even after the vision-specific mental
health subscale was excluded from the NEI-VFQ composite
score (44.4 (23.4) vs. 58.3 (19.5), p,0.001).
The group with low-BDI scores had higher scores for all of the
NEI-VFQ subscales, except general and peripheral vision
(table 2). All the comparison between depressed and non-
depressed group passed the Levene test for equality of variances,
except for colour vision (F = 4.6, p = 0.03). As shown in fig 1,
five subscales remained significant after the Bonferroni correc-
tion for multiple comparisons: general health, ocular pain,
vision-specific social functioning, vision-specific mental health
and vision-specific dependency. The depressed patients experi-
enced the greatest difficulties in the following order: general
health, vision-specific mental health and vision-specific role
difficulties, followed by general vision activities, distance
activities, peripheral vision, vision-specific dependency, near
activities, ocular pain and colour vision (fig 1).
Linear regression analysis showed that the BDI and WVA
scores were significant predictors of the NEI-VFQ composite
score (table 3). The BDI score explained approximately 10.2% of
the variability in the NEI-VFQ composite scores, while the
WVA score explained 33.6% of the variability. The NEI-VFQ
composite score (vision-specific mental health subscale
excluded) was inversely correlated with both the WVA and
BDI scores (r = 20.69, 20.30, p,0.0005) (fig 2A, B). By
contrast, the BDI was not correlated with any objective
measure of visual function, including WVA (r = 20.01,
p = 0.97) or FVS (r = 0.12, p = 0.18) (fig 2C, D). Other clinical
parameters such as age (r = 0.14, p = 0.09), onset age (r = 0.03,
p = 0.71), duration of illness (r = 0.08, p = 0.36), socio-economic
status (r = 0.12, p = 0.15) or education level (r = 20.11,
p = 0.19) showed no correlations with the BDI.
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DISCUSSION
We examined depression and its impact on RP patients’
perception of their vision function and related quality of life.
The results show that depression is common in RP patients and
that the subjective visual function and vision-related quality of
life are affected by the severity of depression, as well as objective
visual disturbance. The prevalence of depression in the study
was 25.7%, much higher than the 10% prevalence in the general
population6 but similar to the rates found in studies of other
chronic disease such as diabetes,17 postmyocardial infarction18
and cancer.19
We found that the RP patients with depression had
significantly lower self-reported vision function compared with
those without depression. In addition, the depression in RP
patients had a strong negative correlation with the self-reported
vision function, while no such associations were found with
objective visual function measures such as the WVA or FVS and
the clinical parameters like age, age at onset or duration of
illness. Therefore, the results indicate that the severity of
depression is not influenced by the progression of RP, and
depression affects self-reported vision function, independent of
the objective disease status of RP. This is consistent with
previous findings in a community population that depression
increases the likelihood of vision-related functional impairment
independent of vision impairment.8
The impact of depression on the patient-reported vision
function was substantial. The average NEI-VFQ composite
score in the patients without depression was higher than in the
patients with depression, with a difference of about 15 points.
This difference in the NEI-VFQ composite score was larger than
the difference between the patients with unilateral and bilateral
visual impairment.20 Miskala et al reported that 3.6- to 16.2-
point decreases in the composite NEI-VFQ score corresponded
to a three-line decrease in the visual acuity of the better-seeing
eye.21 The depressed group had a lower NEI-VFQ average score
for all subscales except general and peripheral vision. This
suggests that the effect of depression on the vision-related
quality of life is pervasive in patients with RP.
Five subscales showed sufficiently large differences between
the depressed and non-depressed groups to survive the multiple
comparisons: vision-specific mental health, vision-specific social
function, vision-specific dependency, general health and ocular
pain. The five subscales share a common feature in that they
measure relatively subjective aspects of vision-related functions
compared with the other subscales. For example, a large
difference was found in the general health subscale, while no
difference was observed in the general vision subscale. The
general health and general vision subscales each comprise one
question to evaluate the subject’s ‘‘overall health’’ and ‘‘eye-
sight,’’ respectively. The ‘‘overall health’’ is more subjective and
is a broader term than ‘‘eyesight,’’ which has a narrower
connotation. Similarly, the vision-specific social function
reflects subjective judgement of their visual impairment, unlike
the subscales that evaluate specific symptomatology as in the
Table 1 Characteristics of all patients and a comparison of the characteristics of depressed and non-depressed patients with retinitis pigmentosa
Characteristics Total (n = 144) BDI,16 (n = 107) BDI>16 (n = 37)
Age, mean years (SD) 38.5 (13.3) 37.8 (13.0) 40.7 (13.9)
Sex, n (%)
Male 83 (57.6) 64 (59.8) 19 (51.4)
Female 61 (42.4) 43 (40.2) 18 (48.6)
Living arrangements, n (%)
Living alone 12 (8.3) 9 (8.4) 3 (8.1)
Living with someone else 126 (91.7) 92 (91.6) 34 (91.9)
Marital status, n (%)
Married 69 (47.9) 56 (52.3) 13 (35.1)
Unmarried or divorced 75 (52.1) 51 (47.7) 24 (64.9)
Education, mean years (SD) 12.8 (3.8) 13.0 (3.7) 12.4 (4.2)
Socio-economic status, mean (SD) 2.9 (1.1) 2.8 (1.1) 3.1 (1.2)
Onset age (years), mean (SD) 19.3 (14.0) 20.0 (13.6) 17.3 (15.0)
Duration of illness, mean (SD 18.7 (12.9) 17.6 (12.1) 22.3 (14.7)
Visual function, mean (SD)
Weighted visual acuity 0.64 (0.47) 0.63 (0.46) 0.68 (0.49)
Binocular visual field score (u) (n = 98) 33.2 (20.8) 32.7 (19.5) (n = 71) 32.9 (24.2) (n = 27)
Functional vis score (n = 98) 22.7 (19.9) 21.3 (18.0) (n = 71) 24.9 (23.4) (n = 27)
NEI-VFQ-25, mean (SD) 52.7 (21.4) 56.7 (19.5) 41.2 (22.6)*
NEI-VFQ-25, mean (SD) (mental subscale not included) 51.9 (20.9) 58.3 (19.5) 44.4 (23.4)*
*p,0.05.
BDI, Beck Depression Inventory; NEI-VFQ, National Eye Institute Visual Function Questionnaire.
Figure 1 National Eye Institute Visual Function Questionnaire (NEI-
VFQ) subscale scores for the depressed and non-depressed patients with
retinitis pigmentosa. BDI, Beck Depression Index; CV, colour vision; DA,
distance activities; GH, general health; GV, general vision; NA, near
activities; OP, ocular pain; PV, peripheral vision; V.D, vision-specific
dependency; V.MH, vision-specific mental health; V.RD, vision-specific
role difficulties; V.SF, vision-specific social functioning. A higher score
represents a better function in the corresponding subscale. *Significance
at the Bonferroni-adjusted (0.05/11) 0.0045 level (two-tailed).
**p,0.0009 (0.01/11). ***p,0.0004 (0.005/11).
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subscales of near-vision or peripheral-vision subscales. The
depressed patients scored an average of 60 points in the ocular
pain subscale, corresponding to mild to moderate levels of pain
or discomfort in and around the eyes, while the patients
without depression had no or mild levels of discomfort. This
finding is comparable with many previous reports that
depression reduces the pain perception threshold22 and implies
that depression might aggravate or induce ocular pain in
patients with RP.
Indirect evidence exists that depression in patients with RP
can be treated successfully, and the vision-related function can
be improved. Brody et al found that self-management education
programme caused 50% reduction in incidence of depression at
6-month follow-up in the patients with advanced macular
Table 2 National Eye Institute Visual Function Questionnaire subscale scores for the depressed and non-depressed patients with retinitis pigmentosa
National Eye Institute Visual Function
Questionnaire subscores BDI,16 (n = 107) BDI>16 (n = 37) p
General health** 39.3 (24.3) 23.0 (24.6) ,0.001
General vision 38.7 (18.9) 35.7 (19.5) 0.408
Ocular pain*** 76.8 (23.4) 59.5 (24.4) ,0.001
Near activities 58.7 (29.6) 46.4 (35.2) 0.039
Distance activities 53.4 (23.4) 41.9 (29.2) 0.017
Vision-specific social functioning* 66.5 (25.7) 51.0 (32.9) 0.004
Vision-specific mental health*** 49.1 (25.0) 26.0 (24.0) ,0.001
Vision-specific role difficulties 44.2 (30.9) 31.8 (28.2) 0.033
Vision-specific dependency*** 64.0 (24.5) 44.4 (30.0) ,0.001
Colour vision 76.2 (31.2) 61.5 (37.5) 0.037
Peripheral vision 50.5 (27.9) 41.9 (28.9) 0.112
*Significance at the Bonferroni-adjusted (0.05/11) 0.0045 level (two-tailed).
**p,0.0009 (0.01/11).
***p,0.0004 (0.005/11).
BDI, Beck Depression Inventory.
Figure 2 Four correlations: between the National Eye Institute Visual Function Questionnaire (NEI-VFQ) composite score and the Beck Depression
Inventory (BDI) and weighted visual acuity (WVA) scores, and between the BDI score and the WVA and functional vis scores.
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degeneration.23 Recently, Rovner et al reported that short-term
psychological treatment aimed at increasing problem-solving
skills lowered the incidence of depression and increased vision-
related function as measured by the NEI-VFQ-17.24
Our study has several important limitations. We did not
diagnose the depression using conventional diagnostic criteria,
but instead measured the symptoms of depression in RP
patients using a self-reported questionnaire, the BDI. Note that
although the BDI is not a diagnostic tool for depression, the BDI
has been confirmed to be a good screening method for
depression.25 Because we included only volunteers, we cannot
exclude the possibility that the patients with more severe
depression did not volunteer as often as the patients with less
severe depression, which may underestimate the prevalence of
depression in RP patients. Moreover, all of the participants were
Korean RP patients, and comparable studies in other countries
would be useful to test the generalisability of our results.
In conclusion, this study showed that RP patients are at
increased risk of depression, which reduces the patients’ vision-
related quality of life. Depression was found to be a unique
contributing factor influencing the vision-related quality of life,
independent of demographic status, objective vision function
and disease severity of RP. As RP is a lifelong disease without
treatment options, the supportive management of vision-related
symptoms is critical for RP patients. Our findings suggest that
depression should be assessed in RP patients and that the
patients may benefit from interventions targeting depression,
which negatively affects their vision-related quality of life.
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